Literature DB >> 12357859

Venlafaxine: a new class of antidepressant.

Julia Hardy1, Spilios Argyropoulos, David J Nutt.   

Abstract

Venlafaxine represents a new class of antidepressant, the serotonin and noradrenaline re-uptake inhibitor (or SNRI). This article discusses its evolution, pharmacological properties and role in the treatment of depression and related disorders, beginning with an outline of the biology of depression.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12357859     DOI： 10.12968/hosp.2002.63.9.1952

Source DB:  PubMed          Journal:  Hosp Med        ISSN： 1462-3935


  2 in total

1.  Duloxetine for childhood depression with pain and dissociative symptoms.

Authors:  Pushpal Desarkar; Anindya Das; Vinod K Sinha
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-05-26       Impact factor: 4.785

2.  Palpitations and Asthenia Associated with Venlafaxine in a CYP2D6 Poor Metabolizer and CYP2C19 Intermediate Metabolizer.

Authors:  Sofia Garcia; Michael Schuh; Anvir Cheema; Herjot Atwal; Paldeep S Atwal
Journal:  Case Rep Genet       Date:  2017-10-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.